ImaginAb, Inc.
ImaginAb, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zr89 + PET Companion Trial | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Early phase 1 | 2026-09-21 | NCT05279027 | |
| Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With | Advanced Melanoma; CD8-PET; Tumor Infiltrating Lymphocyte | Not yet recruiting | Not applicable | 2026-09-15 | NCT07819474 | |
| Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor | non-small cell lung carcinoma | Not yet recruiting | Phase 2 / Phase 3 | 2024-11-29 | NCT06218069 |